The Role of Early Molecular Response in the Management of Chronic Phase CML

PURPOSE OF REVIEW: Although tyrosine kinase inhibitors (TKIs) spectacularly improve the disease burden and the overall survival of chronic myeloid leukemia patients, early identification of a subset of poor TKI responders has been recognized as a critical goal to prevent disease progression in these...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrington, Patrick, Kizilors, Aytug, de Lavallade, Hugues
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410202/
https://www.ncbi.nlm.nih.gov/pubmed/28405921
http://dx.doi.org/10.1007/s11899-017-0375-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410202/
https://www.ncbi.nlm.nih.gov/pubmed/28405921
http://dx.doi.org/10.1007/s11899-017-0375-0

Ejemplares similares